Section Arrow
SPRB.OOTC
- Spruce Biosciences Inc
Quotes are at least 15-min delayed:2025/09/16 05:45 EDT
Pre Market
Last
 10.61
+0.81 (+8.27%)
Bid
10.01
Ask
11.2
High 11.31 
Low 10.01 
Volume 2666 
Regular Hours
Last
 9.8
-2.6 (-20.97%)
Day High 
11.64 
Prev. Close
12.4 
1-M High
12.75 
Volume 
103.42K 
Bid
10.01
Ask
11.2
Day Low
8.05 
Open
10.43 
1-M Low
Market Cap 
6.98M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 8.93 
20-SMA 8.59 
50-SMA 8.33 
52-W High 12.75 
52-W Low 0.057 
Exchange OOTC 
Valuation Estimation
EPS (Current/Estimated)
-86.43/-68.25
Enterprise Value
7.84M
Balance Sheet
Book Value Per Share
23.41
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.91M
Operating Revenue Per Share
0.10
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ATYRaTyr Pharma Inc1.015-5.015-83.17%-- 
Pre Market 1.105 +0.09 +8.87%
ADAPAdaptimmune Therapeutics plc0.0666+0.0106+18.93%-- 
Pre Market 0.0734 +0.0068 +10.21%
MTVAMetaVia Inc1.5+0.8041+115.55%-- 
Pre Market 1.29 -0.21 -14.00%
GLUEMonte Rosa Therapeutics6.93+2.12+44.07%12.33PE
Pre Market 6.24 -0.69 -9.96%
IBRXImmunityBio2.74+0.14+5.38%-- 
Pre Market 2.74 0 0.00%
Quotes are at least 15-min delayed:2025/09/16 05:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.